Thundas, Lovely Hope .
HRN: 21-47-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2022
CEFUROXIME 750MG (VIAL)
06/17/2022
06/23/2022
IVT
220mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes